{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:44:22Z","timestamp":1794336262948,"version":"4.9.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Accurate assessment of progression and disease course in multiple sclerosis (MS) is vital for timely and appropriate clinical intervention. The gradual transition from relapsing-remitting MS (RRMS) to secondary progressive MS (SPMS) is often diagnosed retrospectively with a typical delay of three years. To address this diagnostic delay, we developed a predictive model that uses electronic health records to distinguish between RRMS and SPMS at each individual visit. To enable reliable predictions, conformal prediction was implemented at the individual patient level with a confidence of 93%. Our model accurately predicted the change in diagnosis from RRMS to SPMS for patients who transitioned during the study period. Additionally, we identified new patients who, with high probability, are in the transition phase but have not yet received a clinical diagnosis. Our methodology aids in monitoring MS progression and proactively identifying transitioning patients. An anonymized model is available at\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/msp-tracker.serve.scilifelab.se\/\" ext-link-type=\"uri\">https:\/\/msp-tracker.serve.scilifelab.se\/<\/jats:ext-link>\n                    .\n                  <\/jats:p>","DOI":"10.1038\/s41746-025-01616-z","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T16:40:59Z","timestamp":1745512859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Conformal prediction enables disease course prediction and allows individualized diagnostic uncertainty in multiple sclerosis"],"prefix":"10.1038","volume":"8","author":[{"given":"Akshai Parakkal","family":"Sreenivasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aina","family":"Vaivade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0513-7546","authenticated-orcid":false,"given":"Yassine","family":"Noui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4137-5517","authenticated-orcid":false,"given":"Payam Emami","family":"Khoonsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Burman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8083-2864","authenticated-orcid":false,"given":"Ola","family":"Spjuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Kultima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"1616_CR1","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1177\/1352458514521517","volume":"20","author":"I Katz Sand","year":"2014","unstructured":"Katz Sand, I., Krieger, S., Farrell, C. & Miller, A. E. Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis. Mult. Scler. 20, 1654\u20131657 (2014).","journal-title":"Mult. Scler."},{"key":"1616_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-11-67","volume":"11","author":"B Bejarano","year":"2011","unstructured":"Bejarano, B. et al. Computational classifiers for predicting the short-term course of Multiple sclerosis. BMC Neurol. 11, 67 (2011).","journal-title":"BMC Neurol."},{"key":"1616_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/RLI.0000000000000854","volume":"57","author":"L Storelli","year":"2022","unstructured":"Storelli, L. et al. A deep learning approach to predicting disease progression in multiple sclerosis using magnetic resonance imaging. Invest. Radiol. 57, 423\u2013432 (2022).","journal-title":"Invest. Radiol."},{"key":"1616_CR4","doi-asserted-by":"publisher","first-page":"102242","DOI":"10.1016\/j.msard.2020.102242","volume":"44","author":"I Kleiter","year":"2020","unstructured":"Kleiter, I. et al. The transitional phase of multiple sclerosis: Characterization and conceptual framework. Mult. Scler. Relat. Disord. 44, 102242 (2020).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1616_CR5","doi-asserted-by":"publisher","first-page":"101861","DOI":"10.1016\/j.msard.2019.101861","volume":"38","author":"T Ziemssen","year":"2020","unstructured":"Ziemssen, T. et al. A mixed methods approach towards understanding key disease characteristics associated with the progression from RRMS to SPMS: physicians\u2019 and patients\u2019 views. Mult. Scler. Relat. Disord. 38, 101861 (2020).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1616_CR6","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/brain\/awg081","volume":"126","author":"C Confavreux","year":"2003","unstructured":"Confavreux, C., Vukusic, S. & Adeleine, P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126, 770\u2013782 (2003).","journal-title":"Brain"},{"key":"1616_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/1352458519868990","volume":"26","author":"A Fambiatos","year":"2020","unstructured":"Fambiatos, A. et al. Risk of secondary progressive multiple sclerosis: a longitudinal study. Mult. Scler. 26, 79\u201390 (2020).","journal-title":"Mult. Scler."},{"key":"1616_CR8","doi-asserted-by":"publisher","first-page":"103115","DOI":"10.1016\/j.msard.2021.103115","volume":"54","author":"M Barzegar","year":"2021","unstructured":"Barzegar, M. et al. Early predictors of conversion to secondary progressive multiple sclerosis. Mult. Scler. Relat. Disord. 54, 103115 (2021).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1616_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3390\/medicina55060232","volume":"55","author":"\u0141 Rzepi\u0144ski","year":"2019","unstructured":"Rzepi\u0144ski, \u0141, Zawadka-Kunikowska, M., Maciejek, Z., Newton, J. L. & Zalewski, P. Early clinical features, time to secondary progression, and disability milestones in polish multiple sclerosis patients. Medicina 55, 232 (2019).","journal-title":"Medicina"},{"key":"1616_CR10","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.msard.2014.04.004","volume":"3","author":"B Skoog","year":"2014","unstructured":"Skoog, B., Tedeholm, H., Runmarker, B., Od\u00e9n, A. & Andersen, O. Continuous prediction of secondary progression in the individual course of multiple sclerosis. Mult. Scler. Relat. Disord. 3, 584\u2013592 (2014).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1616_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103590","volume":"72","author":"T Uphaus","year":"2021","unstructured":"Uphaus, T. et al. NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study. EBioMedicine 72, 103590 (2021).","journal-title":"EBioMedicine"},{"key":"1616_CR12","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/brain\/awr336","volume":"135","author":"B Skoog","year":"2012","unstructured":"Skoog, B., Runmarker, B., Winblad, S., Ekholm, S. & Andersen, O. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy. Brain 135, 900\u2013911 (2012).","journal-title":"Brain"},{"key":"1616_CR13","doi-asserted-by":"crossref","unstructured":"Bohr, A. & Memarzadeh, K. Chapter 2 - The rise of artificial intelligence in healthcare applications. In Artificial Intelligence in Healthcare (eds Bohr, A. & Memarzadeh, K.) 25\u201360 (Academic Press, 2020).","DOI":"10.1016\/B978-0-12-818438-7.00002-2"},{"key":"1616_CR14","doi-asserted-by":"publisher","first-page":"e0230219","DOI":"10.1371\/journal.pone.0230219","volume":"15","author":"R Seccia","year":"2020","unstructured":"Seccia, R. et al. Considering patient clinical history impacts performance of machine learning models in predicting course of multiple sclerosis. PLoS ONE 15, e0230219 (2020).","journal-title":"PLoS ONE"},{"key":"1616_CR15","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1177\/1352458518783667","volume":"25","author":"A Manouchehrinia","year":"2019","unstructured":"Manouchehrinia, A. et al. Predicting risk of secondary progression in multiple sclerosis: a nomogram. Mult. Scler. 25, 1102\u20131112 (2019).","journal-title":"Mult. Scler."},{"key":"1616_CR16","first-page":"736","volume":"25","author":"D Ontaneda","year":"2019","unstructured":"Ontaneda, D. Progressive multiple sclerosis. Continuum 25, 736\u2013752 (2019).","journal-title":"Continuum"},{"key":"1616_CR17","doi-asserted-by":"publisher","unstructured":"Banerji, C. R. S., Chakraborti, T., Harbron, C. & MacArthur, B. D. Clinical AI tools must convey predictive uncertainty for each individual patient. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-023-02562-7 (2023).","DOI":"10.1038\/s41591-023-02562-7"},{"key":"1616_CR18","doi-asserted-by":"publisher","first-page":"903600","DOI":"10.3389\/fgene.2022.903600","volume":"13","author":"RL Pierce","year":"2022","unstructured":"Pierce, R. L., Van Biesen, W., Van Cauwenberge, D., Decruyenaere, J. & Sterckx, S. Explainability in medicine in an era of AI-based clinical decision support systems. Front. Genet. 13, 903600 (2022).","journal-title":"Front. Genet."},{"key":"1616_CR19","unstructured":"Vovk, V., Gammerman, A. & Shafer, G. Algorithmic Learning in a Random World. (Springer Science & Business Media, 2005)."},{"key":"1616_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34945-8","volume":"13","author":"H Olsson","year":"2022","unstructured":"Olsson, H. et al. Estimating diagnostic uncertainty in artificial intelligence assisted pathology using conformal prediction. Nat. Commun. 13, 7761 (2022).","journal-title":"Nat. Commun."},{"key":"1616_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106906","volume":"26","author":"S Herman","year":"2023","unstructured":"Herman, S. et al. Disease phenotype prediction in multiple sclerosis. iScience 26, 106906 (2023).","journal-title":"iScience"},{"key":"1616_CR22","first-page":"4765","volume":"30","author":"SM Lundberg","year":"2017","unstructured":"Lundberg, S. M. & Lee, S.-I. A unified approach to interpreting model predictions. Adv. Neural Inf. Process. Syst. 30, 4765\u20134774 (2017).","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"1616_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/ane.12023","volume":"126","author":"O Andersen","year":"2012","unstructured":"Andersen, O. From the Gothenburg cohort to the Swedish multiple sclerosis registry. Acta Neurol. Scand. Suppl. 126, 13\u201319 (2012).","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"1616_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/ane.12425","volume":"132","author":"J Hillert","year":"2015","unstructured":"Hillert, J. & Stawiarz, L. The Swedish MS registry\u2014clinical support tool and scientific resource. Acta Neurol. Scand. 132, 11\u201319 (2015).","journal-title":"Acta Neurol. Scand."},{"key":"1616_CR25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41582-019-0233-x","volume":"15","author":"N Manouchehri","year":"2019","unstructured":"Manouchehri, N. & St\u00fcve, O. Trials and therapies in secondary progressive MS, simplified. Nat. Rev. Neurol. 15, 431\u2013432 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"1616_CR26","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.3389\/fimmu.2018.03116","volume":"9","author":"H Lassmann","year":"2018","unstructured":"Lassmann, H. Pathogenic mechanisms associated with different clinical courses of multiple sclerosis. Front. Immunol. 9, 3116 (2018).","journal-title":"Front. Immunol."},{"key":"1616_CR27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin, F. D. et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83, 278\u2013286 (2014).","journal-title":"Neurology"},{"key":"1616_CR28","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1212\/WNL.0000000000009636","volume":"94","author":"FD Lublin","year":"2020","unstructured":"Lublin, F. D. et al. The 2013 clinical course descriptors for multiple sclerosis: a clarification. Neurology 94, 1088\u20131092 (2020).","journal-title":"Neurology"},{"key":"1616_CR29","doi-asserted-by":"publisher","first-page":"102211","DOI":"10.1016\/j.msard.2020.102211","volume":"43","author":"A Carotenuto","year":"2020","unstructured":"Carotenuto, A. et al. Unraveling diagnostic uncertainty in transition phase from relapsing-remitting to secondary progressive multiple sclerosis. Mult. Scler. Relat. Disord. 43, 102211 (2020).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"1616_CR30","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1093\/brain\/aww173","volume":"139","author":"J Lorscheider","year":"2016","unstructured":"Lorscheider, J. et al. Defining secondary progressive multiple sclerosis. Brain 139, 2395\u20132405 (2016).","journal-title":"Brain"},{"key":"1616_CR31","doi-asserted-by":"publisher","DOI":"10.2196\/16932","volume":"22","author":"T Ziemssen","year":"2020","unstructured":"Ziemssen, T. et al. A physician-completed digital tool for evaluating disease progression (multiple sclerosis progression discussion tool): validation study. J. Med. Internet Res. 22, e16932 (2020).","journal-title":"J. Med. Internet Res."},{"key":"1616_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2023.101286","volume":"40","author":"S S Band","year":"2023","unstructured":"S Band, S. et al. Application of explainable artificial intelligence in medical health: a systematic review of interpretability methods. Inform. Med. Unlocked 40, 101286 (2023).","journal-title":"Inform. Med. Unlocked"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01616-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01616-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01616-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T16:41:01Z","timestamp":1745512861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01616-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1616"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-01616-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.03.01.24303566","asserted-by":"object"}]},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"224"}}